Tag: NOR SCA EUR USA NAM

Hemispherian Receives FDA IND Clearance for First-in-Class Glioblastoma Therapeutic, GLIX1

OSLO, Norway, Aug. 5, 2025 /PRNewswire/ -- Hemispherian AS, a pioneering biotech company developing next-generation therapeutics for aggressive cancers, today announced that the U.S....

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsNOR SCA EUR USA NAM

SkillStorm Launches Cloud & Cybersecurity Certification Tracks to Accelerate Veterans’ Civilian Careers in Tech

BriaCell Announces Proposed Effective Date of Share Consolidation

Investor Alert: Robbins LLP Informs Investors of the Lineage, Inc. Class Action Lawsuit

Tag: NOR SCA EUR USA NAM

Hemispherian Receives FDA IND Clearance for First-in-Class Glioblastoma Therapeutic, GLIX1

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us